Compare FULT & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FULT | AMRX |
|---|---|---|
| Founded | 1882 | 2002 |
| Country | United States | United States |
| Employees | 3400 | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.7B |
| IPO Year | N/A | 2018 |
| Metric | FULT | AMRX |
|---|---|---|
| Price | $20.60 | $12.72 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | ★ $21.40 | $14.75 |
| AVG Volume (30 Days) | ★ 1.9M | 1.7M |
| Earning Date | 04-14-2026 | 05-01-2026 |
| Dividend Yield | ★ 3.74% | N/A |
| EPS Growth | N/A | ★ 157.89 |
| EPS | N/A | ★ 0.22 |
| Revenue | N/A | N/A |
| Revenue This Year | $6.39 | $4.48 |
| Revenue Next Year | $5.52 | $7.13 |
| P/E Ratio | ★ $10.58 | $56.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.33 | $6.69 |
| 52 Week High | $22.99 | $15.42 |
| Indicator | FULT | AMRX |
|---|---|---|
| Relative Strength Index (RSI) | 55.38 | 49.95 |
| Support Level | $19.05 | $12.50 |
| Resistance Level | $21.01 | $12.85 |
| Average True Range (ATR) | 0.50 | 0.37 |
| MACD | 0.12 | 0.08 |
| Stochastic Oscillator | 92.11 | 98.00 |
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.